Skip to content

Study on the anti-aging effect and mechanism of Guben Yiyuan Paste

Study on the anti-aging effect and mechanism of Guben Yiyuan Paste

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000370
Enrollment
Unknown
Registered
2024-09-04
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

frailty

Interventions

Control group:Placebo
Experimental Group:Guben Yiyuan Paste

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1: Age 60 to 85 years old 2: Meet the diagnostic criteria for frailty; 3: Meet the diagnostic criteria for kidney-essence deficiency; 4: Systemic diseases such as cerebrovascular diseases and metabolic diseases are in a stable stage; 5: Stop taking Chinese and Western supplements one week before treatment; 6: Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1: Those with severe physical activity disorders and mental illness; 2: Patients with impaired heart liver kidney and respiratory functions or other serious diseases of other systems AST or ALT values ??exceeding 1.5 times the upper limit of normal values and serum creatinine values ??exceeding the upper limit of normal values; 3: PHQ-9 scale score greater than or equal to 19 points GAD-7 scale score greater than 14 points; 4: Participated in other interventional studies in the past month; 5: Allergic to the test drug.

Design outcomes

Primary

MeasureTime frame
Frailty Index;TCM Syndrome Score;

Secondary

MeasureTime frame
SOD;GAD-7;PSQI;PHQ-9;GSH;MDA;CAT;

Countries

China

Contacts

Public ContactXu Fuping

Guangdong Provincial Hospital of Chinese Medicine

xufuping@163.com15902042439

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026